应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01681 康臣药业
未开盘 05-17 16:08:17
6.980
+0.020
+0.29%
最高
7.130
最低
6.930
成交量
179.30万
今开
7.000
昨收
6.960
日振幅
2.87%
总市值
57.09亿
流通市值
57.09亿
总股本
8.18亿
成交额
1,253万
换手率
0.22%
流通股本
8.18亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康臣药业早盘涨超6% 拟于下周五审议特别股息宣发
新浪港股 · 05-14
康臣药业早盘涨超6% 拟于下周五审议特别股息宣发
港股异动 | 康臣药业(01681)涨超6% 拟于下周五审议特别股息宣发 公司去年营利双增
智通财经 · 05-14
港股异动 | 康臣药业(01681)涨超6% 拟于下周五审议特别股息宣发 公司去年营利双增
康臣药业盘中异动 早盘股价大涨5.21%
自选股智能写手 · 05-14
康臣药业盘中异动 早盘股价大涨5.21%
康臣药业(01681)上涨5.21%,报6.87元/股
金融界 · 05-14
康臣药业(01681)上涨5.21%,报6.87元/股
康臣药业(01681.HK)拟5月24日举行董事局会议以审议并批准特别股息宣发
格隆汇资讯 · 05-13
康臣药业(01681.HK)拟5月24日举行董事局会议以审议并批准特别股息宣发
康臣药业04月03日主力资金流入37万元 连续3日加仓
自选股智能写手 · 04-03
康臣药业04月03日主力资金流入37万元 连续3日加仓
康臣药业(01681)年报观: 业绩稳健,产品丰富,营收盈利双丰收的高派息医药企业
智通财经 · 04-02
康臣药业(01681)年报观: 业绩稳健,产品丰富,营收盈利双丰收的高派息医药企业
康臣药业业绩稳增长,投资价值持续升温
和讯网 · 04-01
康臣药业业绩稳增长,投资价值持续升温
大浪淘沙,股海淘金,康臣药业(01681.HK)—医药价值的践行者
格隆汇 · 04-01
大浪淘沙,股海淘金,康臣药业(01681.HK)—医药价值的践行者
康臣药业(01681)建议采纳2024年购股权计划
智通财经 · 03-28
康臣药业(01681)建议采纳2024年购股权计划
康臣药业(01681)下跌5.19%,报5.48元/股
金融界 · 03-28
康臣药业(01681)下跌5.19%,报5.48元/股
康臣药业盘中异动 快速跳水5.17%报5.481港元
自选股智能写手 · 03-28
康臣药业盘中异动 快速跳水5.17%报5.481港元
康臣药业(01681)股价下跌5.017%,现价港币$5.49
阿斯达克财经 · 03-28
康臣药业(01681)股价下跌5.017%,现价港币$5.49
康臣药业公布2023年业绩 权益股东应占溢利为7.845亿元同比增加约14.9%
新浪港股 · 03-28
康臣药业公布2023年业绩 权益股东应占溢利为7.845亿元同比增加约14.9%
康臣药业(01681)将于6月21日派末期股息每股0.3港元
智通财经 · 03-28
康臣药业(01681)将于6月21日派末期股息每股0.3港元
康臣药业(01681)公布2023年业绩 权益股东应占溢利为7.845亿元 同比增加约14.9% 末期息每股0.3港元
智通财经 · 03-28
康臣药业(01681)公布2023年业绩 权益股东应占溢利为7.845亿元 同比增加约14.9% 末期息每股0.3港元
《公司业绩》康臣药业(01681.HK)全年纯利7.85亿人币升14.9% 派末期息30港仙
阿斯达克财经 · 03-28
《公司业绩》康臣药业(01681.HK)全年纯利7.85亿人币升14.9% 派末期息30港仙
康臣药业(01681):冯仲实已获委任为提名委员会主席
智通财经 · 03-25
康臣药业(01681):冯仲实已获委任为提名委员会主席
康臣药业03月13日遭主力抛售57万元 环比增加375.00%
自选股智能写手 · 03-13
康臣药业03月13日遭主力抛售57万元 环比增加375.00%
康臣药业(01681.HK)将于3月28日举行董事局会议以审批财务报表
格隆汇资讯 · 03-07
康臣药业(01681.HK)将于3月28日举行董事局会议以审批财务报表
加载更多
公司概况
公司名称:
康臣药业
所属市场:
SEHK
上市日期:
--
主营业务:
康臣药业集团有限公司是一家投资控股公司,主要从事生产和销售药品业务。该公司的药品包括肾病药物、对比剂及其他。该公司的子公司包括智达集团有限公司、世纪国际拓展有限公司和宏致有限公司。该公司通过其子公司还从事研发药品业务。
发行价格:
--
{"stockData":{"symbol":"01681","market":"HK","secType":"STK","nameCN":"康臣药业","latestPrice":6.98,"timestamp":1715933297030,"preClose":6.96,"halted":0,"volume":1793000,"delay":0,"floatShares":817901427,"shares":817901427,"eps":1.0701413,"marketStatus":"未开盘","marketStatusCode":0,"change":0.02,"latestTime":"05-17 16:08:17","open":7,"high":7.13,"low":6.93,"amount":12528820,"amplitude":0.028736,"askPrice":6.98,"askSize":29000,"bidPrice":6.97,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":1.0572599511513763,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":6.96,"dividendRate":0.063115,"openAndCloseTimeList":[[1715909400000,1715918400000],[1715922000000,1715932800000]],"volumeRatio":1.0727021648785269,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01681/","defaultTab":"news","newsList":[{"id":"2435537732","title":"康臣药业早盘涨超6% 拟于下周五审议特别股息宣发","url":"https://stock-news.laohu8.com/highlight/detail?id=2435537732","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2435537732?lang=zh_cn&edition=full","pubTime":"2024-05-14 11:26","pubTimestamp":1715657204,"startTime":"0","endTime":"0","summary":"康臣药业(01681)早盘上涨6.13%,现报6.93港元,成交额1069.27万港元。\n 康臣药业昨日发布公告称,公司将于2024年5月24日(即下周五)举行董事局会议,以审议并批准特别股息(特别股息) 的宣发及处理任何其他业务(如有)。如获董事局批准,公司将于董事局会议后另行刊发公告,以载列有关特别股息的详情。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-14/doc-inavehcy3722950.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-14/doc-inavehcy3722950.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435532421","title":"港股异动 | 康臣药业(01681)涨超6% 拟于下周五审议特别股息宣发 公司去年营利双增","url":"https://stock-news.laohu8.com/highlight/detail?id=2435532421","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435532421?lang=zh_cn&edition=full","pubTime":"2024-05-14 10:59","pubTimestamp":1715655582,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康臣药业涨超6%,截至发稿,涨6.43%,报6.95港元,成交额1019.96万港元。消息面上,康臣药业昨日发布公告称,公司将于2024年5月24日举行董事局会议,以审议并批准特别股息 的宣发及处理任何其他业务(如有)。康臣药业2023年实现营业收入25.9亿元人民币,同比增长10.7%;归母净利润为7.85亿元,同比增长14.9%。其中,肾科药物的销售收入为17.4亿元,同比增长约11%;龙头产品尿毒清颗粒销售收入约16.5亿元,同比增长约10.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1120920.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435153549","title":"康臣药业盘中异动 早盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435153549","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435153549?lang=zh_cn&edition=full","pubTime":"2024-05-14 09:34","pubTimestamp":1715650473,"startTime":"0","endTime":"0","summary":"2024年05月14日早盘09时34分,康臣药业股票出现波动,股价急速拉升5.21%。截至发稿,该股报6.870港元/股,成交量21.3万股,换手率0.03%,振幅3.52%。康臣药业股票所在的药品行业中,整体跌幅为0.16%。其相关个股中,联康生物科技集团、康臣药业、康龙化成涨幅较大,振幅较大的相关个股有翰森制药、君圣泰医药-B、康臣药业,振幅分别为3.93%、3.57%、3.52%。康臣药业公司简介:康臣药业集团有限公司是一家投资控股公司,主要从事生产和销售药品业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514093433861ece81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514093433861ece81&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435753582","title":"康臣药业(01681)上涨5.21%,报6.87元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435753582","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435753582?lang=zh_cn&edition=full","pubTime":"2024-05-14 09:33","pubTimestamp":1715650394,"startTime":"0","endTime":"0","summary":"5月14日,康臣药业(01681)盘中上涨5.21%,截至09:33,报6.87元/股,成交118.29万元。康臣药业集团有限公司是一家主要从事现代中成药及医用成像对比剂研发、生产及营销的制药企业,拥有138个品种的药物,包括62个中药品种和76个西药品种,其中33个品种进入国家基本药物目录,69个品种进入国家医保目录。公司在国内建有4个生产基地,员工逾2500人,累计纳税额达30亿元,品牌价值近50亿元,拥有47项专利授权,包括12项国际专利授权,并在全国31个省市自治区设立70多个联络点,产品远销30多个国家和地区。截至2023年年报,康臣药业营业总收入25.9亿元、净利润7.85亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/14093340633623.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435637338","title":"康臣药业(01681.HK)拟5月24日举行董事局会议以审议并批准特别股息宣发","url":"https://stock-news.laohu8.com/highlight/detail?id=2435637338","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2435637338?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:31","pubTimestamp":1715607067,"startTime":"0","endTime":"0","summary":"格隆汇5月13日丨康臣药业(01681.HK)公告,公司将于2024年5月24日(星期五)举行董事局会议,以审议并批准特别股息宣发及处理任何其他业务(如有):如获董事局批准,公司将于董事局会议后另行刊发公司,以载列有关特别股息的详情。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132131188b01b1eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132131188b01b1eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424925860","title":"康臣药业04月03日主力资金流入37万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2424925860","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424925860?lang=zh_cn&edition=full","pubTime":"2024-04-03 16:16","pubTimestamp":1712132205,"startTime":"0","endTime":"0","summary":"04月03日, 康臣药业股价跌1.74%,报收5.64元,成交金额576万元,换手率0.12%,振幅4.01%,量比0.75。康臣药业今日主力资金净流入37万元,连续3日净流入,上一交易日主力净流入63万元,今日环比减少41.27%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为28.57%,平均涨幅为0.39%。该股近5个交易日下跌1.05%,主力资金累计净流入311万元;近20日主力资金累计净流入157万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040316174687d9b5c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040316174687d9b5c1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424704260","title":"康臣药业(01681)年报观: 业绩稳健,产品丰富,营收盈利双丰收的高派息医药企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2424704260","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424704260?lang=zh_cn&edition=full","pubTime":"2024-04-02 07:51","pubTimestamp":1712015519,"startTime":"0","endTime":"0","summary":"而2023年财报新鲜出炉的康臣药业便是其中之一。硬核财务指标预示价值向上通道营收盈利双丰收,派息比率突破40%,是此次康臣药业年报向投资者透露出的最直观的信息。同业对比来看,截至3月26日,在A股的73家中药上市公司中,目前有16家公司正式披露了2023年年报,其中的14家实现归母净利润同比正增长。2023年,康臣药业分部也继续扮演了稳定公司业绩的重要基石。此外,公司多个在研影像产品进展顺利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1097430.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424599728","title":"康臣药业业绩稳增长,投资价值持续升温","url":"https://stock-news.laohu8.com/highlight/detail?id=2424599728","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2424599728?lang=zh_cn&edition=full","pubTime":"2024-04-01 23:48","pubTimestamp":1711986495,"startTime":"0","endTime":"0","summary":"康臣药业在最近发布的年报中展现了良好的业绩表现,引起了投资者的关注。这表明市场对康臣药业的投资价值和未来发展持有认可和信心。康臣药业具备一些确定性因素,使其成为投资者关注的对象。其次,康臣药业持续实现业绩增长,展现出较强的经营能力和适应能力。在医药板块升温、公司业绩增长和分红政策的支持下,康臣药业未来的投资价值令人期待。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404020017298ae4b3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404020017298ae4b3f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424482017","title":"大浪淘沙,股海淘金,康臣药业(01681.HK)—医药价值的践行者","url":"https://stock-news.laohu8.com/highlight/detail?id=2424482017","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2424482017?lang=zh_cn&edition=full","pubTime":"2024-04-01 22:05","pubTimestamp":1711980303,"startTime":"0","endTime":"0","summary":"公司目前动态市盈率仅在5倍左右,低估值优势明显,考虑到公司所具备的多重确定性催化,后续表现值得期待。","market":"us","thumbnail":"https://img7.gelonghui.com/column/3.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/3.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/715027","is_publish_highlight":false,"gpt_icon":0},{"id":"2422686154","title":"康臣药业(01681)建议采纳2024年购股权计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2422686154","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422686154?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:29","pubTimestamp":1711618178,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)发布公告,公司于2013年12月2日采纳了2013年购股权计划。根据2013年购股权计划的条款,除非另行终止或修订,否则2013年购股权计划将自其通过之日起10年内有效,并于2023年12月1日到期。2013年购股权计划到期后,将不再要约或授予购股权。于本公告日期,2013年购股权计划中仍有5046.39万份已授出但尚未行使的购股权。鉴于2013年购股权计划到期,董事局建议根据经修订的上市规则第17章采纳2024年购股权计划,自2023年1月1日起生效,以激励或奖励合资格参与人士为集团做出的贡献。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094778.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422598133","title":"康臣药业(01681)下跌5.19%,报5.48元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422598133","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422598133?lang=zh_cn&edition=full","pubTime":"2024-03-28 14:11","pubTimestamp":1711606302,"startTime":"0","endTime":"0","summary":"3月28日,康臣药业盘中下跌5.19%,截至14:11,报5.48元/股,成交1317.46万元。康臣药业集团有限公司是一家主要从事现代中成药及医用成像对比剂研发、生产及营销的制药企业,拥有138个品种的药物,包括62个中药品种和76个西药品种,其中33个品种进入国家基本药物目录,69个品种进入国家医保目录。截至2023年中报,康臣药业营业总收入11.2亿元、净利润3.48亿元。3月28日,康臣药业披露2023财年年报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/28141140033331.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422713392","title":"康臣药业盘中异动 快速跳水5.17%报5.481港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422713392","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422713392?lang=zh_cn&edition=full","pubTime":"2024-03-28 14:11","pubTimestamp":1711606301,"startTime":"0","endTime":"0","summary":"2024年03月28日下午盘14时11分,康臣药业股票出现波动,股价急速下跌5.17%。截至发稿,该股报5.481港元/股,成交量232.4万股,换手率0.29%,振幅6.75%。康臣药业股票所在的药品行业中,整体跌幅为0.10%。该信息摘要如下:康臣药业公布2023年业绩,收入为人民币25.9亿元,同比增加约10.7%。权益股东应占溢利为人民币7.845亿元,同比增加约14.9%。其中,肾科药物的销售收入于2023年约为人民币17.4亿元,较上年同比增长约11.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032814114287e7caea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032814114287e7caea&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422947133","title":"康臣药业(01681)股价下跌5.017%,现价港币$5.49","url":"https://stock-news.laohu8.com/highlight/detail?id=2422947133","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422947133?lang=zh_cn&edition=full","pubTime":"2024-03-28 14:07","pubTimestamp":1711606020,"startTime":"0","endTime":"0","summary":"[下跌股]康臣药业(01681) 股价在下午02:07比前收市价下跌5.017%,现股价为港币$5.49。至目前为止,今日最高价为$5.87,而最低价为$5.49。总成交量为219.2万股,总成交金额为港币$1.245千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403282358/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422182589","title":"康臣药业公布2023年业绩 权益股东应占溢利为7.845亿元同比增加约14.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422182589","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422182589?lang=zh_cn&edition=full","pubTime":"2024-03-28 13:08","pubTimestamp":1711602522,"startTime":"0","endTime":"0","summary":"康臣药业(01681)公布2023年业绩,收入为人民币25.9亿元,同比增加约10.7%。 权益股东应占溢利为人民币7.845亿元,同比增加约14.9%。 每股基本盈利0.99元,拟派末期股息每股0.3港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-28/doc-inapvxxu3636846.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-28/doc-inapvxxu3636846.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422864461","title":"康臣药业(01681)将于6月21日派末期股息每股0.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422864461","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422864461?lang=zh_cn&edition=full","pubTime":"2024-03-28 12:15","pubTimestamp":1711599329,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)发布公告,该公司将于2024年6月21日派末期股息每股0.3港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094473.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422185021","title":"康臣药业(01681)公布2023年业绩 权益股东应占溢利为7.845亿元 同比增加约14.9% 末期息每股0.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422185021","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422185021?lang=zh_cn&edition=full","pubTime":"2024-03-28 12:05","pubTimestamp":1711598726,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业 公布2023年业绩,收入为人民币25.9亿元,同比增加约10.7%。权益股东应占溢利为人民币7.845亿元,同比增加约14.9%。每股基本盈利0.99元,拟派末期股息每股0.3港元。其中,肾科药物的销售收入于2023年约为人民币17.4亿元,较上年同比增长约11.0%。集团龙头产品尿毒清颗粒继续保持稳健增长,实现销售收入约人民币16.5亿元,较上年同比增长约10.2%,稳居肾病口服现代中成药品类领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094464.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422189927","title":"《公司业绩》康臣药业(01681.HK)全年纯利7.85亿人币升14.9% 派末期息30港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2422189927","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422189927?lang=zh_cn&edition=full","pubTime":"2024-03-28 12:05","pubTimestamp":1711598700,"startTime":"0","endTime":"0","summary":"康臣药业(01681.HK) 公布截至去年12月底止全年业绩,营业额25.9亿元人民币(下同),按年升10.7%。纯利7.85亿元,按年升14.9%;每股盈利99分。派末期息30港仙,按年持平。(jl/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-27 16:25。)过往派息公布日期派息事项派息内容2023/08/24中期业绩普通股息:港元 0.152023/03/23末期业绩普通股息:港元 0.30002022/08/26中期业绩无派息 2022/03/23末期业绩普通股息:港元 0.2000AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220720140431349_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220720140431349_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1338271/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422594592","title":"康臣药业(01681):冯仲实已获委任为提名委员会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2422594592","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422594592?lang=zh_cn&edition=full","pubTime":"2024-03-25 18:37","pubTimestamp":1711363071,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康臣药业(01681)发布公告,苏元福因有意投入更多时间于其他私人事务已辞任独立非执行董事职务,且不再为公司提名委员会主席以及公司审核委员会及公司薪酬委员会各自的成员,自2024年3月25日起生效。自2024年3月25日起生效及在苏元福辞任后:冯仲实已获委任为提名委员会主席;陈玉君已获委任为薪酬委员会成员;及张丽华已获委任为审核委员会成员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091588.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2419257175","title":"康臣药业03月13日遭主力抛售57万元 环比增加375.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419257175","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419257175?lang=zh_cn&edition=full","pubTime":"2024-03-13 16:16","pubTimestamp":1710317804,"startTime":"0","endTime":"0","summary":"03月13日, 康臣药业股价涨0.17%,报收5.92元,成交金额387万元,换手率0.08%,振幅2.88%,量比1.31。康臣药业今日主力资金净流出57万元,上一交易日主力净流出12万元,今日环比增加375.00%。该股近5个交易日上涨4.20%,主力资金累计净流出126万元;近20日主力资金累计净流出41万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313161727877b727a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313161727877b727a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417765950","title":"康臣药业(01681.HK)将于3月28日举行董事局会议以审批财务报表","url":"https://stock-news.laohu8.com/highlight/detail?id=2417765950","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2417765950?lang=zh_cn&edition=full","pubTime":"2024-03-07 21:07","pubTimestamp":1709816855,"startTime":"0","endTime":"0","summary":"格隆汇3月7日丨康臣药业(01681.HK)发布公告,公司将于2024年3月28日举行董事局会议,以审阅及批准公司及其附属公司截至2023年12月31日止年度经审核综合财务报表;考虑派发末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072107418b131554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072107418b131554&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinaconsun.com","stockEarnings":[{"period":"1week","weight":0.0975},{"period":"1month","weight":0.2577},{"period":"3month","weight":0.327},{"period":"6month","weight":0.5076},{"period":"1year","weight":0.4633},{"period":"ytd","weight":0.4633}],"compareEarnings":[{"period":"1week","weight":0.0311},{"period":"1month","weight":0.2032},{"period":"3month","weight":0.1967},{"period":"6month","weight":0.1203},{"period":"1year","weight":-0.0088},{"period":"ytd","weight":0.147}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康臣药业集团有限公司是一家投资控股公司,主要从事生产和销售药品业务。该公司的药品包括肾病药物、对比剂及其他。该公司的子公司包括智达集团有限公司、世纪国际拓展有限公司和宏致有限公司。该公司通过其子公司还从事研发药品业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.042737},{"month":2,"riseRate":0.545455,"avgChangeRate":0.01876},{"month":3,"riseRate":0.454545,"avgChangeRate":0.012988},{"month":4,"riseRate":0.727273,"avgChangeRate":0.072436},{"month":5,"riseRate":0.545455,"avgChangeRate":0.030294},{"month":6,"riseRate":0.4,"avgChangeRate":0.002034},{"month":7,"riseRate":0.4,"avgChangeRate":-0.035002},{"month":8,"riseRate":0.5,"avgChangeRate":0.005025},{"month":9,"riseRate":0.5,"avgChangeRate":-0.014484},{"month":10,"riseRate":0.3,"avgChangeRate":-0.035377},{"month":11,"riseRate":0.6,"avgChangeRate":0.014008},{"month":12,"riseRate":0.5,"avgChangeRate":0.019335}],"exchange":"SEHK","name":"康臣药业","nameEN":"CONSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康臣药业,01681,康臣药业股票,康臣药业股票老虎,康臣药业股票老虎国际,康臣药业行情,康臣药业股票行情,康臣药业股价,康臣药业股市,康臣药业股票价格,康臣药业股票交易,康臣药业股票购买,康臣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康臣药业(01681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康臣药业(01681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}